Mon. Sep 27th, 2021


The makers of the Pfizer-BiONTech Covid-19 vaccine say they have found a South African partner to manufacture their jab locally.

Under the agreement, Biovac, which is based in Cape Town, will be supplied with the ingredients from facilities in Europe.

Reports say it will complete the last step in the manufacturing process, known as fill and finish.
Biovac, which aims to produce one hundred million doses annually, is scheduled to start supplying vaccines to the market by the end of the year.

Leave a Reply

Your email address will not be published. Required fields are marked *